Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer

Citation
Y. Nonami et al., Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer, J CARD SURG, 42(4), 2001, pp. 561-564
Citations number
12
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF CARDIOVASCULAR SURGERY
ISSN journal
00219509 → ACNP
Volume
42
Issue
4
Year of publication
2001
Pages
561 - 564
Database
ISI
SICI code
0021-9509(200108)42:4<561:ISWATG>2.0.ZU;2-3
Abstract
Even when gross pathologic specimens are available, evaluation is always co mplicated due to the difficulty in distinguishing the pathologic diagnosis of an adenocarcinoma as a pulmonary metastasis of the breast or lung. in th is paper, we describe the usefulness of a preoperative immunohistochemical study using gross cystic disease fluid protein-15 (GCDFP-15). A 50-year-old woman, who had undergone a right radical mastectomy due to an infiltrating ductal carcinoma 4 years previously, was admitted because of an abnormal s hadow on chest roentgenograpy. A chest CT scan showed a nodule 20 min in diameter with an irregular margin and vascular involvement in the S-3 region of the right lung. Though the s pecimen from a percutaneous CT guided needle biopsy revealed characteristic pathologic findings of a primary lung adenocarcinoma under H.E. stain, whi ch was recommended for lobar resection, we re-examined that specimen inummo histochemically, which disclosed that the tumor cells were negative for the antibody to pulmonary surfactant apoprotein and were positive for GCDFP-15 antibody. Therefore, the diagnosis of a metastatic breast carcinoma in the lung was e stablished. Upon her request, a wedge resection of the right upper lobe inc luding the tumor was performed under video-assisted thoracoscopic surgery ( VATS). Her postoperative course was uneventful.